Document is current
Any future updates will be listed below
-
Authors
Desikan, R S
Schork, A J
Wang, Y
Witoelar, A
Sharma, M
McEvoy, L K
Holland, D
Brewer, J B
Chen, C-H
Thompson, W K
Harold, D
Williams, J
Owen, M J
O'Donovan, M C
Pericak-Vance, M A
Mayeux, R
Haines, J L
Farrer, L A
Schellenberg, G D
Heutink, P
Singleton, A B
Brice, A
Wood, N W
Hardy, J
Martinez, M https://orcid.org/0000-0003-2180-4537
Choi, S H
DeStefano, A
Ikram, M A https://orcid.org/0000-0003-0372-8585
Bis, J C
Smith, A
Fitzpatrick, A L
Launer, L
van Duijn, C
Seshadri, S
Ulstein, I D
Aarsland, D
Fladby, T
Djurovic, S
Hyman, B T
Snaedal, J
Stefansson, H
Stefansson, K
Gasser, T
Andreassen, O A
Dale, A M
,
- License Information
-
More Information
Article History
Received: 4 September 2014
Revised: 29 November 2014
Accepted: 8 January 2015
First Online: 17 February 2015
Competing interests
: Disclosures Dr. Anders M. Dale is a Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is also a member of the Scientific Advisory Board of Human Longevity, Inc. (HLI), and receives funding through research agreements with General Electric Healthcare (GEHC) and Medtronic, Inc. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. Dr. Linda K. McEvoy has stock options in CorTechs Labs, Inc. Dr. James B. Brewer holds stock options in CorTechs Labs, Inc and serves on the advisory board and receives financial support from the Eli Lilly Biomarker Unit (Amyvid). Dr. Brewer also receives research support from General Electric and Janssen Alzheimer Immunotherapy.
